Cord Blood America CEO Interview Details the Value of New 'Afford-A-Cord' Program

LAS VEGAS, June 4, 2010 - PRNewswire. Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI.ob - News), said today that its co-founder and CEO, Matthew Schissler, reviewed the reasons for and significant details about its new "Afford-A-Cord" program in an interview with analyst Francis Gaskins.

Cord Blood America Announces Early Start to Groundbreaking 'Afford-A-Cord' Program

LAS VEGAS, June, 2010 - PRNewswire-FirstCall.

"Because of the overwhelmingly positive response to CBAI's initial announcement, we pushed the last two weeks to launch early. It wouldn't be fair for a parent to miss out on the program because of simple lag time. We have been able to button up all the details on the plan, which we believe will allow more people to take advantage of this important medical insurance policy," said Matthew Schissler, Cord Blood America co-founder and CEO.

Cord Blood America (OTC BB: CBAI) is the stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally. This clipping service will keep you up-to-date on accomplishments in this important health arena.

Cord Blood Stem Cells - A Global Market Overview

Global cord blood stem cells market for 2010 is estimated at about US$4.5 billion. The market is further projected to register a robust CAGR of 27.3% during the period 2006-2015 to reach US$15 billion by 2015.